BPC-157 vs. TB-500: A Research Comparison
BPC-157 and TB-500 are two of the most-studied peptides in tissue and cell-research literature, and they're frequently discussed side by side. They are distinct compounds with different origins and different mechanisms studied. Here's an objective look.
What is BPC-157?
BPC-157 ("Body Protection Compound-157") is a synthetic pentadecapeptide — a 15-amino-acid sequence derived from a protein found in gastric juice. In the research literature it has been studied in models of angiogenesis (new blood-vessel formation) and tissue/cell-migration pathways.
What is TB-500?
TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring protein. It has been studied in research on actin regulation and cell migration — a different mechanistic pathway than BPC-157.
Key differences at a glance
| BPC-157 | TB-500 | |
|---|---|---|
| Class | Pentadecapeptide (gastric-derived) | Thymosin Beta-4 fragment |
| Research focus | Angiogenesis & cell-migration models | Actin regulation & cell migration |
| Origin | Synthetic, sequence from gastric protein | Synthetic fragment of a natural protein |
Why they're often studied together
Because the two are studied in different but complementary pathways, researchers sometimes investigate them in combination — which is why a BPC-157 + TB-500 blend exists as a single research product.
The bottom line
They are not the same compound and are not interchangeable. Which a study uses depends entirely on the research question and pathway of interest.
Explore the research line: BPC-157 · TB-500 · BPC-157 + TB-500 Blend — all third-party HPLC tested, COA included.